Hepatitis C virus genotyping using an oligonucleotide microarray based on the NS5B sequence

Journal of Clinical Microbiology

Volumn 48, Issue 11, 2010, Pages 3910-3917

  Gryadunov, Dimitry ^a   Nicot, Florence ^b   Dubois, Martine ^b   Mikhailovich, Vladimir ^a   Zasedatelev, Alexander ^a   Izopet, Jacques ^b  

^a ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^b CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTRUCTURAL PROTEIN 5B; OLIGONUCLEOTIDE;

ARTICLE; BIOCHIP; GENE SEQUENCE; GENOTYPE; HEPATITIS C VIRUS; HYBRIDIZATION; HYDROGEL; MICROARRAY ANALYSIS; NUCLEIC ACID AMPLIFICATION; PHYLOGENY; PRIORITY JOURNAL; RNA ISOLATION; VIRAL GENETICS; VIRUS GENOME;

GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; VIRAL NONSTRUCTURAL PROTEINS; VIROLOGY;

HEPATITIS C VIRUS;

EID: 78049498155     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01265-10     Document Type: Article

References (51)

1. Bonny, C., H. Fontaine, T. Poynard, C. Hezode, D. Larrey, P. Marcellin, M. Bourliere, J. P. Bronowicki, P. Merle, J. P. Zarski, T. Sapey, C. Guillemard, S. Ughetto, C. Henquell, C. Nicolas, C. Roche, K. Randl, G. Bommelaer, and A. Abergel. 2006. Effectiveness of interferon plus ribavirin combination in the treatment of naive patients with hepatitis C virus type 5. A French multicentre retrospective study. Aliment. Pharmacol. Ther. 24:593-600.
2. Cantaloube, J. F., S. Laperche, P. Gallian, F. Bouchardeau, X. de Lamballerie, and P. de Micco. 2006. Analysis of the 5′ noncoding region versus the NS5b region in genotyping hepatitis C virus isolates from blood donors in France. J. Clin. Microbiol. 44:2051-2056.
3. Chen, Z., and K. E. Weck. 2002. Hepatitis C virus genotyping: interrogation of the 5′ untranslated region cannot accurately distinguish genotypes 1a and 1b. J. Clin. Microbiol. 40:3127-3134.
4. Chevaliez, S., M. Bouvier-Alias, R. Brillet, and J. M. Pawlotsky. 2009. Hepatitis C virus (HCV) genotype 1 subtype identification in new HCV drug development and future clinical practice. PLoS One 4:e8209.
5. Choo, Q. L., K. H. Richman, J. H. Han, K. Berger, C. Lee, C. Dong, C. Gallegos, D. Coit, R. Medina-Selby, P. J. Barr, et al. 1991. Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. U. S. A. 88:2451-2455.
6. Costi, C., C. M. da Silva, N. N. Da Fre, T. Grandi, F. I. Hamester, A. Zaha, C. Niel, and M. L. Rossetti. 2009. Colorimetric microwell plate reverse-hybridization assay for detection and genotyping of hepatitis C virus. J. Virol. Methods 162:75-80.
7. Erhardt, A., K. Deterding, Y. Benhamou, M. Reiser, X. Forns, S. Pol, J. L. Calleja, S. Ross, H. C. Spangenberg, J. Garcia-Samaniego, M. Fuchs, J. Enriquez, J. Wiegand, J. Stern, K. Wu, G. Kukolj, M. Marquis, P. Beaulieu, G. Nehmiz, and J. Steffgen. 2009. Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatment. Antivir. Ther. 14:23-32.
8. Fried, M. W., M. L. Shiffman, K. R. Reddy, C. Smith, G. Marinos, F. L. Goncales, Jr., D. Haussinger, M. Diago, G. Carosi, D. Dhumeaux, A. Craxi, A. Lin, J. Hoffman, and J. Yu. 2002. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med. 347:975-982.
9. Fung, J., C. L. Lai, I. Hung, J. Young, C. Cheng, D. Wong, and M. F. Yuen. 2008. Chronic hepatitis C virus genotype 6 infection: response to pegylated interferon and ribavirin. J. Infect. Dis. 198:808-812.
10. Germer, J. J., D. W. Majewski, M. Rosser, A. Thompson, P. S. Mitchell, T. F. Smith, S. Elagin, and J. D. Yao. 2003. Evaluation of the TRUGENE HCV 5′NC genotyping kit with the new GeneLibrarian module 3.1.2 for genotyping of hepatitis C virus from clinical specimens. J. Clin. Microbiol. 41:4855-4857.
11. Hadziyannis, S. J., and J. S. Koskinas. 2004. Differences in epidemiology, liver disease and treatment response among HCV genotypes. Hepatol. Res. 29:129-135.
12. Hraber, P. T., W. Fischer, W. J. Bruno, T. Leitner, and C. Kuiken. 2006. Comparative analysis of hepatitis C virus phylogenies from coding and noncoding regions: the 5′ untranslated region (UTR) fails to classify subtypes. Virol. J. 3:103.
13. Kieffer, T. L., C. Sarrazin, J. S. Miller, M. W. Welker, N. Forestier, H. W. Reesink, A. D. Kwong, and S. Zeuzem. 2007. Telaprevir and pegylated interferon-alpha-2a inhibit wild-type and resistant genotype 1 hepatitis C virus replication in patients. Hepatology 46:631-639. (Pubitemid 47436107)
14. Kuiken, C., P. Hraber, J. Thurmond, and K. Yusim. 2008. The hepatitis C sequence database in Los Alamos. Nucleic Acids Res. 36:D512-D516. (Pubitemid 351149775)
15. Laperche, S., F. Lunel, J. Izopet, S. Alain, P. Deny, G. Duverlie, C. Gaudy, J. M. Pawlotsky, J. C. Plantier, B. Pozzetto, V. Thibault, F. Tosetti, and J. J. Lefrere. 2005. Comparison of hepatitis C virus NS5b and 5′ noncoding gene sequencing methods in a multicenter study. J. Clin. Microbiol. 43:733-739.
16. Legrand-Abravanel, F., P. Colson, H. Leguillou-Guillemette, L. Alric, I. Ravaux, F. Lunel-Fabiani, M. Bouviers-Alias, P. Trimoulet, M. L. Chaix, C. Hezode, J. Foucher, H. Fontaine, A. M. Roque-Afonso, M. Gassin, E. Schvoerer, C. Gaudy, B. Roche, M. Doffoel, L. D'Alteroche, S. Vallet, Y. Baazia, B. Pozzetto, V. Thibault, J. B. Nousbaum, D. Roulot, H. Coppere, T. Poinard, C. Payan, and J. Izopet. 2009. Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy. J. Med. Virol. 81:2029-2035.
17. Legrand-Abravanel, F., F. Nicot, A. Boulestin, K. Sandres-Saune, J. P. Vinel, L. Alric, and J. Izopet. 2005. Pegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infection. J. Med. Virol. 77:66-69.
18. Legrand-Abravanel, F., F. Nicot, and J. Izopet. 2010. New NS5B polymerase inhibitors for hepatitis C. Expert Opin. Invest. Drugs 19:963-975.
19. Legrand-Abravanel, F., K. Sandres-Saune, K. Barange, L. Alric, J. Moreau, P. Desmorat, J. P. Vinel, and J. Izopet. 2004. Hepatitis C virus genotype 5: epidemiological characteristics and sensitivity to combination therapy with interferon-alpha plus ribavirin. J. Infect. Dis. 189:1397-1400.
20. Liang, Y., H. Ishida, O. Lenz, T. I. Lin, O. Nyanguile, K. Simmen, R. B. Pyles, N. Bourne, M. Yi, K. Li, and S. M. Lemon. 2008. Antiviral suppression vs restoration of RIG-I signaling by hepatitis C protease and polymerase inhibitors. Gastroenterology 135:1710-1718.
21. Manns, M. P., H. Wedemeyer, and M. Cornberg. 2006. Treating viral hepatitis C: efficacy, side effects, and complications. Gut 55:1350-1359.
22. Mao, H., H. Zhang, J. Zhao, Z. Lu, G. Jin, S. Gu, H. Wang, and Y. Wang. 2010. Clinical evaluation of a colorimetric oligonucleotide chip for genotyping hepatitis C virus. Clin. Biochem. 43:214-219.
23. Martro, E., V. Gonzalez, A. J. Buckton, V. Saludes, G. Fernandez, L. Matas, R. Planas, and V. Ausina. 2008. Evaluation of a new assay in comparison with reverse hybridization and sequencing methods for hepatitis C virus genotyping targeting both 5′ noncoding and nonstructural 5b genomic regions. J. Clin. Microbiol. 46:192-197.
24. McCown, M. F., S. Rajyaguru, S. Kular, N. Cammack, and I. Najera. 2009. GT-1a or GT-1b subtype-specific resistance profiles for hepatitis C virus inhibitors telaprevir and HCV-796. Antimicrob. Agents Chemother. 53:2129-2132.
25. McHutchison, J. G., G. T. Everson, S. C. Gordon, I. M. Jacobson, M. Sulkowski, R. Kauffman, L. McNair, J. Alam, and A. J. Muir. 2009. Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection. N. Engl. J. Med. 360:1827-1838.
26. Mikhailovich, V., D. Gryadunov, A. Kolchinsky, A. A. Makarov, and A. Zasedatelev. 2008. DNA microarrays in the clinic: infectious diseases. Bioessays 30:673-682. (Pubitemid 351899654)
27. Murphy, D. G., B. Willems, M. Deschenes, N. Hilzenrat, R. Mousseau, and S. Sabbah. 2007. Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 5′ untranslated region sequences. J. Clin. Microbiol. 45:1102-1112.
28. Nasedkina, T. V., N. A. Guseva, O. A. Gra, O. N. Mityaeva, A. V. Chudinov, and A. S. Zasedatelev. 2009. Diagnostic microarrays in hematologic oncology: applications of high- and low-density arrays. Mol. Diagn. Ther. 13:91-102.
29. Nicot, F., L. Alric, K. Barange, S. Métivier, J. M. Dramard, J. M. Combis, B. Castan, J. J. Meurisse, J. L. Payen, D. Garipuy, H. Desmorat, J. M. Peron, S. Thebault, T. Morin, C. Renou, P. Barel, B. Guerin, Y. Imbert, S. Sire, K. Sauné, E. Chatelut, and J. Izopet. Influence of HCV genotype 1 subtypes on the virus response to peg interferon alpha-2a plus ribavirin therapy. J. Med. Virol., in press.
30. Nicot, F., F. Legrand-Abravanel, K. Sandres-Saune, A. Boulestin, M. Dubois, L. Alric, J. P. Vinel, C. Pasquier, and J. Izopet. 2005. Heterogeneity of hepatitis C virus genotype 4 strains circulating in south-western France. J. Gen. Virol. 86:107-114.
31. Nyanguile, O., B. Devogelaere, L. Vijgen, W. Van den Broeck, F. Pauwels, M. D. Cummings, H. L. De Bondt, A. M. Vos, J. M. Berke, O. Lenz, G. Vandercruyssen, K. Vermeiren, W. Mostmans, P. Dehertogh, F. Delouvroy, S. Vendeville, K. VanDyck, K. Dockx, E. Cleiren, P. Raboisson, K. A. Simmen, and G. C. Fanning. 2010. 1a/1b subtype profiling of nonnucleoside polymerase inhibitors of hepatitis C virus. J. Virol. 84:2923-2934.
32. Page, R. D. 1996. TreeView: an application to display phylogenetic trees on personal computers. Comput. Appl. Biosci. 12:357-358.
33. Pan'kov, S. V., V. R. Chechetkin, O. G. Somova, O. V. Antonova, O. V. Moiseeva, D. V. Prokopenko, R. A. Yurasov, D. A. Gryadunov, and A. V. Chudinov. 2009. Kinetic effects on signal normalization in oligonucleotide microchips with labeled immobilized probes. J. Biomol. Struct. Dyn. 27:235-244.
34. Park, J. C., J. M. Kim, O. J. Kwon, K. R. Lee, Y. G. Chai, and H. B. Oh. 2010. Development and clinical evaluation of a microarray for hepatitis C virus genotyping. J. Virol. Methods 163:269-275.
35. Ross, R. S., S. Viazov, B. Wolters, and M. Roggendorf. 2008. Towards a better resolution of hepatitis C virus variants: CLIP sequencing of an HCV core fragment and automated assignment of genotypes and subtypes. J. Virol. Methods 148:25-33.
36. Roulot, D., V. Bourcier, V. Grando, P. Deny, Y. Baazia, H. Fontaine, F. Bailly, L. Castera, V. De Ledinghen, P. Marcellin, R. Poupon, M. Bourliere, J. P. Zarski, and F. Roudot-Thoraval. 2007. Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection. J. Viral Hepat. 14:460-467.
37. Rubina, A. Y., A. Kolchinsky, A. A. Makarov, and A. S. Zasedatelev. 2008. Why 3-D? Gel-based microarrays in proteomics. Proteomics 8:817-831.
38. Rubina, A. Y., S. V. Pan'kov, E. I. Dementieva, D. N. Pen'kov, A. V. Butygin, V. A. Vasiliskov, A. V. Chudinov, A. L. Mikheikin, V. M. Mikhailovich, and A. D. Mirzabekov. 2004. Hydrogel drop microchips with immobilized DNA: properties and methods for large-scale production. Anal. Biochem. 325:92-106.
39. Sandres-Saune, K., P. Deny, C. Pasquier, V. Thibaut, G. Duverlie, and J. Izopet. 2003. Determining hepatitis C genotype by analyzing the sequence of the NS5b region. J. Virol. Methods 109:187-193.
40. Sarrazin, C., T. L. Kieffer, D. Bartels, B. Hanzelka, U. Muh, M. Welker, D. Wincheringer, Y. Zhou, H. M. Chu, C. Lin, C. Weegink, H. Reesink, S. Zeuzem, and A. D. Kwong. 2007. Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir. Gastroenterology 132:1767-1777.
41. Sarrazin, C., and S. Zeuzem. 2010. Resistance to direct antiviral agents in patients with hepatitis C virus infection. Gastroenterology 138:447-462.
42. Simmonds, P. 2004. Genetic diversity and evolution of hepatitis C virus - 15 years on. J. Gen. Virol. 85:3173-3188.
43. Simmonds, P., J. Bukh, C. Combet, G. Deleage, N. Enomoto, S. Feinstone, P. Halfon, G. Inchauspe, C. Kuiken, G. Maertens, M. Mizokami, D. G. Murphy, H. Okamoto, J. M. Pawlotsky, F. Penin, E. Sablon, I. T. Shin, L. J. Stuyver, H. J. Thiel, S. Viazov, A. J. Weiner, and A. Widell. 2005. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42:962-973.
44. Sohn, Y. H., S. Y. Ko, M. H. Kim, and H. B. Oh. 2010. Performance evaluation of the Abbott RealTime HCV Genotype II for hepatitis C virus genotyping. Clin. Chem. Lab. Med. 48:469-474.
45. Stuyver, L., W. van Arnhem, A. Wyseur, F. Hernandez, E. Delaporte, and G. Maertens. 1994. Classification of hepatitis C viruses based on phylogenetic analysis of the envelope 1 and nonstructural 5B regions and identification of five additional subtypes. Proc. Natl. Acad. Sci. U. S. A. 91:10134-10138.
46. Stuyver, L., A. Wyseur, W. van Arnhem, F. Hernandez, and G. Maertens. 1996. Second-generation line probe assay for hepatitis C virus genotyping. J. Clin. Microbiol. 34:2259-2266.
47. Thomas, F., F. Nicot, K. Sandres-Saune, M. Dubois, F. Legrand-Abravanel, L. Alric, J. M. Peron, C. Pasquier, and J. Izopet. 2007. Genetic diversity of HCV genotype 2 strains in south western France. J. Med. Virol. 79:26-34.
48. Thompson, J. D., T. J. Gibson, F. Plewniak, F. Jeanmougin, and D. G. Higgins. 1997. The CLUSTAL-X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25:4876-4882.
49. Verbeeck, J., M. J. Stanley, J. Shieh, L. Celis, E. Huyck, E. Wollants, J. Morimoto, A. Farrior, E. Sablon, M. Jankowski-Hennig, C. Schaper, P. Johnson, M. Van Ranst, and M. Van Brussel. 2008. Evaluation of Versant hepatitis C virus genotype assay (LiPA) 2.0. J. Clin. Microbiol. 46:1901-1906.
50. Weck, K. 2005. Molecular methods of hepatitis C genotyping. Expert Rev. Mol. Diagn. 5:507-520.
51. Younossi, Z., J. Kallman, and J. Kincaid. 2007. The effects of HCV infection and management on health-related quality of life. Hepatology 45:806-816. (Pubitemid 46450632)